Rare Disease Control and Orphan Drug Act revisions - Follow-up to secure patients’ rights
The 3rd amendment of the Rare Disease Control and Orphan Drug Act was publicized on January 14th, 2015. In order to meet the requirements of the amendment, sub-laws were proposed and revised.

　　The Enforcement Rules of the Rare Disease Control and Orphan Drug Act had been revised and publicized by the end of 2015. The Subsidy Regulations of International Medical Cooperation for Rare Disorders, the Reward and Subsidy Regulations of Rare Disease Prevention and Treatment Work, and the Regulations of Rare Diseases and Rare Genetic Diseases Defect Care Services had been publicized in 2016. It is TFRD’s hope that these regulations will bring more supports to patients and researchers of rare disorders.